SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001214659-24-009741
Filing Date
2024-05-22
Accepted
2024-05-22 10:21:23
Documents
2

Document Format Files

Seq Description Document Type Size
1 d522242424b3.htm 424B3 372595
2 GRAPHIC graph.jpg GRAPHIC 48504
  Complete submission text file 0001214659-24-009741.txt   440663
Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ
Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ 44 (0)1235 888300
Biodexa Pharmaceuticals Plc (Filer) CIK: 0001643918 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-278040 | Film No.: 24971925
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)